Wei-Liang Chen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Metabolic Syndrome

Monoclonal Antibody

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sheng-Chieh Lin, Sing-Hua Tsou, Chien-Yin Kuo, Wei-Liang Chen, Kuan-Wen Wu, Chih-Li Lin, Chien-Ning Huang
Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. International journal of molecular sciences 24 (12) (2023)
Sheng-Chieh Lin, Sing-Hua Tsou, Chien-Yin Kuo, Wei-Liang Chen, Kuan-Wen Wu, Chih-Li Lin, Chien-Ning Huang
Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. International journal of molecular sciences 24 (12) (2023)
Sheng-Chieh Lin, Sing-Hua Tsou, Chien-Yin Kuo, Wei-Liang Chen, Kuan-Wen Wu, Chih-Li Lin, Chien-Ning Huang
Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. International journal of molecular sciences 24 (12) (2023)
Edy Kornelius, Sing-Hua Tsou, Ching-Chi Chang, Ying-Jui Ho, Sheng-Chieh Lin, Wei-Liang Chen, Chien-Ning Huang, Chih-Li Lin
Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells' Inflammation and Dysfunction. Biomolecules 12 (10) (2022)